AI Verdict
NECB has stronger fundamentals based on our AI analysis.
NERV vs NECB Fundamental Comparison
| Metric | NERV | NECB |
|---|---|---|
| Revenue | $0.0 | $154.1M |
| Net Income | $-293.4M | $44.4M |
| Net Margin | N/A | 28.8% |
| ROE | N/A | 12.6% |
| ROA | -299.5% | 2.2% |
| Current Ratio | 36.28x | N/A |
| Debt/Equity | N/A | 0.20x |
| EPS | $-34.67 | $3.25 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NERV vs NECB: Frequently Asked Questions
Is NERV or NECB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NECB has stronger fundamentals. NERV is rated STRONG SELL (85% confidence) while NECB is rated BUY (68% confidence). This is not investment advice.
How does NERV compare to NECB fundamentally?
Minerva Neurosciences, Inc. has ROE of N/A vs NorthEast Community Bancorp, Inc./MD/'s 12.6%. Net margins are N/A vs 28.8% respectively.
Which stock pays higher dividends, NERV or NECB?
NERV has a dividend yield of N/A or no dividend while NECB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NERV or NECB for long term?
For long-term investing, consider that NERV has STRONG SELL rating with 85% confidence, while NECB has BUY rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NERV vs NECB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NERV vs NECB, the AI consensus favors NECB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.